Wikipedia -WSS

Wikipedia

author：entertainment 2025-08-04 05:22:29 - browse：9345

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM, a progressive disease that leads to fatal heart failure if left untreated. The FDA, which is not required to follow the advice of advisers, is expected to make a final decision on patisiran by Oct. 8.

“It’s like a light wind blowing in favor of patisiran over placebo,” said David Cella, a neurologist at the Northwestern University Feinberg School of Medicine who voted in favor of patisiran. David Moliterno, a cardiologist at the University of Kentucky, added that “the good news in this story is that while there may be a small benefit, it doesn’t look like there’s a signal for harm.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： CZI to create biohub to build anti

WSS

Why some fertility treatments produce more boy babies

Decentralized clinical trials need collaboration to achieve wider use

Medical students need to learn the potent medicine of empathy

STAT Readout Newsletter: Biotech news today

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Asahi Kasei to buy Calliditas, picking up kidney disease drug

leisure time

Wikipedia

Wikipedia

Alkermes shareholders re

Roivant's CEO is a star, but biotech's black hole persists

Apple is now the first public company to be valued at $3 trillion

Beyond aggravation: Constipation is an American epidemic

Bright Health sells Medicare Advantage business to Molina

Smaller biotechs seek to piggyback on weight loss drug boom

DIEP, the 'gold standard' of breast reconstruction, is under threat

Beyond aggravation: Constipation is an American epidemic

Peter Hotez and the public health issue of online harassment

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

hotspot

ADCs take center stage as promising cancer treatments

New research sheds light on how often breast cancer is overdiagnosed

Cassava Sciences’ Alzheimer’s clinical trials should be halted

J&J lung cancer data amount to new salvo against AstraZeneca

Study on Amgen’s bispecific immunotherapy produces positive data

Questions loom on AstraZeneca cancer drug as safety concerns ebb

explore

entertainment

leisure time

explore